Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:1330-1331 (14 June), doi:10.1136/bmj.39605.497431.DB
Melissa Sweet
1 Sydney
| The first 150 words of the full text of this article appear below. |
A sudden fall in the use of hormone replacement therapy (HRT) in Australia has been associated with a drop in the incidence of breast cancer among older women, a study has shown (Medical Journal of Australia 2008;188:641-4).
A 40% decline in HRT prescribing between 2001 and 2003 was associated with a 6.7% fall in the incidence of breast cancer standardised for age in women aged 50 and older.
Women younger than 50 showed no significant change in incidence of breast cancer, the researchers found.
The fall in sales of HRT followed negative publicity arising from the womens health initiative study, published in 2002 (JAMA 2002;288:321-33).
The authors of the new study, from the Cancer Council New South Wales, the Australian National University, and the University of Oxfords cancer epidemiology unit, noted that the study did not prove a causal connection.
However, they were unable to find any evidence
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses